Alpha Tau Medical Shares Outstanding 2020-2024 | DRTS
Alpha Tau Medical shares outstanding from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Alpha Tau Medical Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 70 |
| 2023 | 69 |
| 2022 | 64 |
| 2021 | 41 |
| 2020 | 40 |
| 2019 | 34 |
| Alpha Tau Medical Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | |
| 2024-03-31 | 70 |
| 2023-03-31 | 69 |
| 2022-12-31 | 64 |
| 2022-09-30 | 69 |
| 2022-06-30 | 68 |
| 2022-03-31 | 48 |
| 2021-12-31 | 41 |
| 2021-09-30 | 41 |
| 2021-06-30 | 41 |
| 2021-03-31 | 41 |
| 2020-12-31 | |
| 2020-09-30 | 6 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.183B | $0.000B |
| Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. Alpha Tau Medical Ltd., formerly known as Healthcare Capital Corp., is based in JERUSALEM. | |||